Rheumatology

Living with PAN: Your Care Team and Long-Term Health

At a Glance

Living with Polyarteritis nodosa (PAN) requires a multidisciplinary medical team led by a rheumatologist. Long-term care focuses on monitoring for disease flares using regular blood tests and clinical checks, while actively managing the side effects of chronic treatments like corticosteroids.

Living with Polyarteritis nodosa (PAN) is a long-term journey that requires more than just a single doctor. Because PAN is a multisystem disease—meaning it can attack many different parts of the body at once—you will likely need a diverse team of experts to manage your health and monitor for any signs that the disease is returning ^[1]^[2].

Building Your Care Team

Think of your medical team as a coordinated unit. While a Rheumatologist usually serves as the “quarterback” or lead coordinator, you may also need:

Neurologist: To monitor for nerve damage or the risk of strokes ^[3].
Gastroenterologist: To watch for issues with blood flow to the gut or intestines ^[2].
Dermatologist: To manage skin-related symptoms like nodules or ulcers ^[4].
Vascular Surgeon: To monitor and, if necessary, treat any microaneurysms that were found during your diagnosis ^[5].

Monitoring for Relapse

Even when you are in remission (when the disease is no longer active), long-term surveillance is critical ^[6]. Relapses can happen, particularly as your doctors begin to lower (taper) your dose of steroids ^[7]. Your team will use a combination of tools to watch for a “flare”:

Birmingham Vasculitis Activity Score (BVAS): This is a checklist doctors use to track symptoms across your entire body. A high score at the time of your diagnosis can sometimes predict a higher risk of future relapses ^[8].
Regular Labs: Frequent blood tests to check for markers of inflammation, such as CRP (C-reactive protein) and ESR (sedimentation rate) ^[9].
Clinical Checks: You should be on the lookout for a return of “constitutional” symptoms like unexplained fever, sudden weight loss, or extreme fatigue ^[9]^[10].

Managing the Long-Term Toll of Treatment

The medications that save your life can also have their own long-term challenges. Your care team will work with you to manage these risks:

Bone Health: Chronic use of corticosteroids (like prednisone) can lead to Glucocorticoid-Induced Osteoporosis (GIOP), which weakens your bones ^[11]. Guidelines recommend early monitoring with bone density scans and often the use of medications called bisphosphonates to prevent fractures ^[12]^[13].
Infection Risk: Powerful immunosuppressants like cyclophosphamide increase your risk of infections. Your doctor may prescribe preventative medications or specific vaccines to keep you safe ^[14]^[15].
Day-to-Day Lifestyle: Working with a dietitian can help if you experience gastrointestinal issues or weight changes from steroids. Pacing yourself and finding low-impact ways to stay active can help manage extreme fatigue ^[16].
Mental Health and ‘Scan Anxiety’: The emotional weight of living with a chronic, relapsing condition is significant. Many patients experience anxiety before follow-up scans or lab tests. It is important to discuss your quality of life and functional recovery—not just your lab numbers—with your medical team ^[16]^[17].

Active self-advocacy and a supportive medical team are your most powerful tools for navigating life with PAN and ensuring that your long-term health is protected ^[18].

Common questions in this guide

What kind of doctors treat Polyarteritis nodosa?

A rheumatologist usually leads the care team for PAN. Depending on your symptoms, you may also need to see a neurologist, gastroenterologist, dermatologist, or vascular surgeon to manage issues in specific body systems.

How do doctors monitor for a PAN relapse?

Doctors use regular blood tests to check for inflammation, alongside tools like the Birmingham Vasculitis Activity Score (BVAS) to track your symptoms. They also watch for constitutional signs like unexplained fever, sudden weight loss, or extreme fatigue.

What are the long-term side effects of PAN treatment?

Long-term use of corticosteroids like prednisone can cause weakened bones (osteoporosis). Powerful immunosuppressants also increase your risk of infections, which is why your doctor may prescribe protective medications and monitor your bone health closely.

What symptoms signal that my PAN is flaring up?

Red flag symptoms of a PAN relapse include unexplained fever, sudden weight loss, extreme fatigue, new skin lumps, or persistent abdominal pain. If you experience these symptoms, particularly while lowering your steroid dose, contact your care team immediately.

Curated prompts to bring to your next appointment.

1.Who is the lead 'quarterback' of my care team, and which other specialists (like a neurologist or nephrologist) should I be seeing regularly?
2.What is my current 'Birmingham Vasculitis Activity Score' (BVAS), and what specific labs will we use to watch for a relapse?
3.What is our long-term plan to taper my steroids, and are there 'steroid-sparing' medications we can use to reduce my side effects?
4.Since I've been on steroids for a while, when should I have my next DEXA bone density scan, and should I be taking a bisphosphonate for bone protection?
5.What are the 'red flag' symptoms I should watch for that might signal the disease is returning or that I have a serious infection?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (18)

1
Clinical Approach to Diagnosis and Therapy of Polyarteritis Nodosa.
Hočevar A, Tomšič M, Perdan Pirkmajer K
Current rheumatology reports 2021; (23(3)):14 doi:10.1007/s11926-021-00983-2.
PMID: 33569653
2
Polyarteritis nodosa presenting with severe upper gastrointestinal bleeding: a case report.
Xiao XY, Niu Y, Liu PP, et al.
Journal of medical case reports 2024; (18(1)):616 doi:10.1186/s13256-024-04892-7.
PMID: 39707462
3
Successful Treatment of Polyarteritis Nodosa With Multifocal Intracranial and Mesenteric Stenoses Using Endovascular Stenting and Tocilizumab.
Nobre M, Carrilho M, Dias A, et al.
Cureus 2025; (17(8)):e89607 doi:10.7759/cureus.89607.
PMID: 40922821
4
Fluctuating facial edema as a rare manifestation of cutaneous polyarteritis nodosa: Case report and review of the literature.
Gaviria A, Patino W, Ruiz M, et al.
Journal of cutaneous pathology 2020; (47(11)):1076-1079 doi:10.1111/cup.13833.
PMID: 32761868
5
Successful surgical intervention for rectal perforation due to polyarteritis nodosa: report of a case.
Yoshiya K, Imamura Y, Nakaji Y, et al.
Surgical case reports 2017; (3(1)):43 doi:10.1186/s40792-017-0316-0.
PMID: 28290145
6
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients.
Rohmer J, Nguyen Y, Trefond L, et al.
Journal of autoimmunity 2023; (139()):103093 doi:10.1016/j.jaut.2023.103093.
PMID: 37536165
7
Early skeletal muscle manifestations in polyarteritis nodosa and ANCA-associated vasculitis.
Shimojima Y, Nomura S, Ushiyama S, et al.
Autoimmunity reviews 2024; (23(7-8)):103602 doi:10.1016/j.autrev.2024.103602.
PMID: 39153646
8
Birmingham vasculitis activity score at diagnosis is a significant predictor of relapse of polyarteritis nodosa.
Oh YJ, Ahn SS, Park ES, et al.
Rheumatology international 2017; (37(5)):685-694 doi:10.1007/s00296-017-3706-5.
PMID: 28341881
9
Asymmetrical muscular disorder with normal creatine kinase (CK) and electromyography (EMG): the challenging diagnosis of muscular polyarteritis nodosa (MPAN), case report and literature review.
Dib A, Lequain H, Fenouil T, et al.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(7)).
PMID: 42370969
10
Putting the Pieces Into Place: A Case of Systemic Polyarteritis Nodosa.
Brodell D, Scott G, Plovanich M
Cureus 2020; (12(6)):e8442 doi:10.7759/cureus.8442.
PMID: 32642356
11
Glucocorticoid-induced osteoporosis update.
Adami G, Saag KG
Current opinion in rheumatology 2019; (31(4)):388-393 doi:10.1097/BOR.0000000000000608.
PMID: 31045947
12
Management of glucocorticoid-related osteoporotic vertebral fracture.
Wong SPY, Mok CC
Osteoporosis and sarcopenia 2020; (6(1)):1-7 doi:10.1016/j.afos.2020.02.002.
PMID: 32226826
13
Glucocorticoid-induced Osteoporosis.
Whittier X, Saag KG
Rheumatic diseases clinics of North America 2016; (42(1)):177-89, x.
PMID: 26611558
14
Treatment of membranous nephropathy: time for a paradigm shift.
Ruggenenti P, Fervenza FC, Remuzzi G
Nature reviews. Nephrology 2017; (13(9)):563-579 doi:10.1038/nrneph.2017.92.
PMID: 28669992
15
Lupus nephritis complicated by cytomegalovirus colitis, aspergillosis and brain abscess.
Campos Costa F, Freitas J, Oliveira M, Malcata A
Lupus 2019; (28(12)):1495-1497 doi:10.1177/0961203319872549.
PMID: 31474190
16
Improving quality of life in vasculitis patients.
Aitken M, Basu N
Rheumatology (Oxford, England) 2020; (59(Suppl 3)):iii132-iii135 doi:10.1093/rheumatology/kez546.
PMID: 32348508
17
Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis.
Morales E, Rúa-Figueroa I, Callejas Rubio JL, et al.
Nefrologia 2025; (45(1)):15-58 doi:10.1016/j.nefroe.2025.01.001.
PMID: 39855968
18
Recent pathogenetic insights and therapeutic advances in ANCA-associated vasculitis.
Sagy I, Jayne DRW
Annals of the rheumatic diseases 2026; (85(4)):588-602 doi:10.1016/j.ard.2025.11.024.
PMID: 41469274

This page provides educational information about living with Polyarteritis nodosa (PAN). It does not replace professional medical advice. Always consult your rheumatologist about your specific care plan and symptoms.

Get notified when new evidence is published on Polyarteritis nodosa.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents